These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 324366)

  • 21. Comparison of the uricosuric effect of sulfinpyrazone (anturan) and zoxazolamine (flexin).
    MONTGOMERY DB; OGRYZLO MA
    Can Med Assoc J; 1960 Oct; 83(17):885-8. PubMed ID: 13772195
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacologic evaluation of the renal handling of uric acid and oxypurines.
    Hiroshige K; Takasugi M; Yuu K; Kuroiwa A
    Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1268-75. PubMed ID: 7853759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Renal excretion of uric acid in rats].
    Boudry JF; Roch-Ramel F
    J Physiol (Paris); 1969; 61 Suppl 2():232. PubMed ID: 5384797
    [No Abstract]   [Full Text] [Related]  

  • 24. Morin (3,5,7,2',4'-pentahydroxyflavone) exhibits potent inhibitory actions on urate transport by the human urate anion transporter (hURAT1) expressed in human embryonic kidney cells.
    Yu Z; Fong WP; Cheng CH
    Drug Metab Dispos; 2007 Jun; 35(6):981-6. PubMed ID: 17325024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of probenecid and benzbromarone on gluconeogenesis in isolated rat liver cells.
    Rodilla F; Sánchez-Beltrán MJ; Izquierdo R; Gómez-Ruiz MD; Cabo J
    Rev Esp Fisiol; 1989 Dec; 45(4):391-4. PubMed ID: 2631163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Saluretic and uricosuric effects of (6, 7-dichloro-2-methyl=1-oxo-2-phenyl-5-indanyloxy) acetic acid (MK-196) in the chimpanzee.
    Fanelli GM; Bohn DL; Scriabine A; Beyer KH
    J Pharmacol Exp Ther; 1977 Feb; 200(2):402-12. PubMed ID: 14250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal effects of uricosuric agents in the chimpanzee.
    Fanelli GM; Bohn DL; Reilly SS
    J Pharmacol Exp Ther; 1971 Jun; 177(3):591-9. PubMed ID: 5568813
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacology of uricosuric drugs.
    Kippen I; Whitehouse MW; Klinenberg JR
    Ann Rheum Dis; 1974 Jul; 33(4):391-6. PubMed ID: 4213293
    [No Abstract]   [Full Text] [Related]  

  • 29. Urate clearance in Cebus monkeys.
    Skeith MD; Healey LA
    Am J Physiol; 1968 Mar; 214(3):582-4. PubMed ID: 4966347
    [No Abstract]   [Full Text] [Related]  

  • 30. Benemid, flexin and anturane as uricosuric agents.
    LAVIETES PH
    Conn Med; 1962 Sep; 26():561-2. PubMed ID: 14462935
    [No Abstract]   [Full Text] [Related]  

  • 31. [Variations in fecal elimination of uric acid in 8 patients treated with benzbromarone].
    Dupuich Y; Chandelier C; Niquet G
    LARC Med; 1983 Mar; 3(3):189-90. PubMed ID: 6865603
    [No Abstract]   [Full Text] [Related]  

  • 32. Paradoxical retention of uric acid by uricosuric drugs in low dosage.
    YU TF; GUTMAN AB
    Proc Soc Exp Biol Med; 1955 Nov; 90(2):542-7. PubMed ID: 13273509
    [No Abstract]   [Full Text] [Related]  

  • 33. Clearance experiments on the effect of probenecid on urate excretion in the rabbit.
    Moller JV
    Acta Pharmacol Toxicol (Copenh); 1965; 23(4):321-8. PubMed ID: 5899690
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal excretion and uricosuric properties of halofenate, a hypolipidemic-uricosuric agent, in the chimpanzee.
    Fanelli GM; Bohn DL; Reilly SS; Baer JE
    J Pharmacol Exp Ther; 1972 Feb; 180(2):377-96. PubMed ID: 5010680
    [No Abstract]   [Full Text] [Related]  

  • 35. [Uric acid-lowering effect of a combination of benzbromarone and allopurinol--studies under standardized dietary conditions].
    Löffler W; Gröbner W; Zöllner N
    Arzneimittelforschung; 1983; 33(12):1687-91. PubMed ID: 6686776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metabolic spectrum of halofenate.
    Ryan JR
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):239-43. PubMed ID: 51838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification of uricosuric states based upon response to pharmacologic inhibitors of urate transport.
    Diamond HS; Meisel AD
    Adv Exp Med Biol; 1977; 76B():63-71. PubMed ID: 855764
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of halofenate and probenecid on serum lipids and uric acid in hyperlipidemic, hyperuricemic adults.
    Bassett DR; Mikkelsen WM; Buckingham RB; Block WD; Sidiq M; Shakibai A; DiGaetano R; Liou LL
    Clin Pharmacol Ther; 1977 Sep; 22(3):340-51. PubMed ID: 330079
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal hypouricemia: incomplete combined defect.
    Kawai S; Yamada M; Osawa G
    Nihon Jinzo Gakkai Shi; 1994 Aug; 36(8):955-61. PubMed ID: 7933674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperuricemia induced by ethambutol.
    Postlethwaite AE; Bartel AG; Kelley WN
    Adv Exp Med Biol; 1974; 41():763-7. PubMed ID: 4832606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.